BUY Viyash Scientific Limited — Narendra Solanki, Anand Rathi

Entry₹266Inferred
Target₹310
Total upside +16.54%
Stop lossNot given
CMP₹218.395h ago
Active-17.90%+41.95%upside left 10 mo left

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 30 Oct, 9:24 pm IST
11 supporting3 neutral0 opposing
Supports the BUY call (11)

2 other SEBI-registered advisors have active long-term BUY calls on this stock, with 1 issued in the last 14 days

Advisor consensus · same horizon·29 Oct · yesterday

Viyash Scientific has completed the acquisition of BioForLife Italia S.r.l.

BSE · Company Update·1 Oct · 4w ago

(opens in new tab)
Neutral / worth noting (3)

Nothing found in this tip’s window yet.

Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.